FR2960780B1 - Medicament pour le traitement de la maladie de parkinson - Google Patents

Medicament pour le traitement de la maladie de parkinson

Info

Publication number
FR2960780B1
FR2960780B1 FR1002404A FR1002404A FR2960780B1 FR 2960780 B1 FR2960780 B1 FR 2960780B1 FR 1002404 A FR1002404 A FR 1002404A FR 1002404 A FR1002404 A FR 1002404A FR 2960780 B1 FR2960780 B1 FR 2960780B1
Authority
FR
France
Prior art keywords
parkinson
medicine
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1002404A
Other languages
English (en)
Other versions
FR2960780A1 (fr
Inventor
Andreas Hartmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to FR1002404A priority Critical patent/FR2960780B1/fr
Priority to PCT/IB2011/052460 priority patent/WO2011154887A1/fr
Publication of FR2960780A1 publication Critical patent/FR2960780A1/fr
Application granted granted Critical
Publication of FR2960780B1 publication Critical patent/FR2960780B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1002404A 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson Active FR2960780B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1002404A FR2960780B1 (fr) 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson
PCT/IB2011/052460 WO2011154887A1 (fr) 2010-06-07 2011-06-06 Méllitine pour son utilisation dans le traitement de la maladie de parkinson

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1002404A FR2960780B1 (fr) 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson

Publications (2)

Publication Number Publication Date
FR2960780A1 FR2960780A1 (fr) 2011-12-09
FR2960780B1 true FR2960780B1 (fr) 2012-08-10

Family

ID=42635109

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1002404A Active FR2960780B1 (fr) 2010-06-07 2010-06-07 Medicament pour le traitement de la maladie de parkinson

Country Status (1)

Country Link
FR (1) FR2960780B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140356343A1 (en) * 2011-12-05 2014-12-04 Key Neurosciences Sas Composition for treating parkinson's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918281B1 (fr) * 2007-09-25 2009-11-06 Assist Publ Hopitaux De Paris Medicament pour le traitement de la maladie de parkinson.
FR2918282B1 (fr) * 2007-07-02 2009-10-02 Assistance Publique Hopitaux P Medicament pour le traitement de la maladie de parkinson

Also Published As

Publication number Publication date
FR2960780A1 (fr) 2011-12-09

Similar Documents

Publication Publication Date Title
JP2015501783A5 (fr)
HK1163500A1 (en) Pharmaceutical composition for the treatment of heart diseases
EP3466408C0 (fr) Composition pharmaceutique liquide destinée au traitement d'une maladie de l'oeil postérieur
HK1258028A1 (zh) 人類抗體及其在神經疾病治療中的診斷和治療用途
ZA201100034B (en) Pharmaceutical compositions for treatment of parkinson's disease
IL221744A (en) Use of a combination of compounds to prepare a drug to treat Parkinson's disease
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
HK1184370A1 (zh) 用於治療疼痛的藥物組合
EP3628326C0 (fr) Méthodes et substances permettant de traiter la maladie de pompe
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
IL260078B (en) Therapy used to treat Gaucher disease
FR2918282B1 (fr) Medicament pour le traitement de la maladie de parkinson
EP2563395A4 (fr) Traitement avec l'anticorps anti-s1p de patients atteints de maladies oculaires
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
PT2774991T (pt) Sistema de entrega de fármaco para utilização no tratamento ou diagnóstico de distúrbios neurológicos
UA109359C2 (xx) Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном
FR2953723B1 (fr) Composition pharmaceutique destinee au traitement des pathologies orthopediques
FR2960780B1 (fr) Medicament pour le traitement de la maladie de parkinson
FR2980972B1 (fr) Formulations pour le diagnostic et le traitement de cancers hormonodependants et de cancers des organes de synthese d'hormones steroidiennes.
FR2918281B1 (fr) Medicament pour le traitement de la maladie de parkinson.
FR2953412B1 (fr) Medicament pour le traitement des ulceres gastro-intestinaux
ZA201402477B (en) Compounds for use in the treatment of alzheimer's disease
FR2965178B1 (fr) Composition pharmaceutique utilise dans le traitement de la maladie d'alzheimer
FR2959122B1 (fr) Systeme de preparation et/ou d'administration de fluides de traitement medical
FR2955495B1 (fr) Medicament pour la reduction de la cholesterolemie

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

CL Concession to grant licences

Name of requester: KEY NEUROSCIENCES, FR

Effective date: 20160322

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8